Summary
We investigated atrophic alterations in different regions of the corpus callosum in Alzheimer’s disease (AD) and vascular dementia (VD) with respect to clinical changes. 32 patients with AD (NINCDS-ADRDA criteria), 17 patients with VD (NINDS-AIREN criteria) and 13 healthy control subjects were included. 3-D MRI sequences were acquired using a 1.5 T MRI scanner. The size of the corpus callosum and its subdivisions was sampled on 5 mid-saggital slices using a personal computer-based software. Total callosal size was significantly reduced in AD but not in VD. Furthermore, the most rostral parts of the corpus callosum were significantly smaller in AD when compared to controls. Again, these changes were not found in patients with VD. Severity of dementia was significantly correlated with the size of the midbody of the corpus callosum in AD. Callosal atrophy in AD may reflect the severity and pattern of cortical neuronal damage occurring mostly in the inferior frontal, anterior parietal and midtemporal regions. Correlations between regional callosal atrophy and severity of dementia indicate that interhemispheric cortico-cortical disconnections may contribute to the dementia syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Biegon A, Eberling JL, Richardson BC, Roos MS, Wong STS, Reed BR, Jagust J (1994) Human corpus callosum in aging and Alzheimer’s disease: a magnetic resonance imaging study. Neurobiol Aging 15: 393–397
De Lacoste MC, Kirkpatrick JB, Ross ED (1985) Topography of the human corpus callosum. J Neuropathol Exp Neurol 44: 578–591
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental-state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Friedlinger M, Schad LR, Blüml S, Tritsch B, Lorenz WJ (1995) Rapid automatic brain volumetry on the basis of multispectral 3D MR imaging data on personal computers. Comput Med Imaging Graph 19(2): 185–205
Janowsky JS, Jeffrey AK, Carper RA (1996) Atrophy of the corpus callosum in Alzheimer’s disease versus healthy aging. J Am Geriatr Soc 44: 798–803
Kaufer DI, Miller BL, Itti L, Fairbanks LA, Li J, Fishman J, Kushi J, Cummings JL (1997) Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer’s disease. Neurology 48: 978–985
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of department of health an human services task force on Alzheimer’s disease. Neurology 34: 939–965
Pantel J, Schröder J, Schad LR, Friedlinger M, Knopp MV, Schmitt R, Geißler M, Blüml S, Essig M, Sauer H (1997) Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol Med 27: 221–229
Reisberg B, Ferris SH (1988) The brief cognitive rating scale (BCRS). Psychopharmacol Bull 24: 629–636
Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250–260
Vermesch P, Sheltens P, Barkhof F, Steinling M, Leys D (1993) Evidence for atrophy of the corpus callosum in Alzheimer’s disease. Eur Neurol 34: 83–86
Weis S, Jellinger K, Wenger E (1991) Morphometry of the corpus callosum in normal aging and Alzheimer’s disease. J Neural Transm 33: 35–38
Weis S, Kimbacher M, Wenger E, Neuhold A (1993) Morphometric analysis of the corpus callosum using MR: correlation of measurements with aging in healthy individuals. AJNR 14: 637–645
Yamanouchi H, Sugiura S, Shimada H (1989) Decrease of nerve fibres in the anterior corpus callosum of senile dementia of Alzheimer’s type. J Neurol 236: 491–492
Yamauchi H, Fukuyama H, Harada K, Nabatame H, Ogawa M, Ouchi Y, Kimura J, Konishi J (1993) Callosal atrophy paralles decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer’s disease. Arch Neurol 50: 1070–1074
Yamauchi H, Funuyama H, Ogawa M, Ouchi Y, Kimura J (1994) Callosal atrophy in patients withlacunar infarctions and extensive leukoaraiosis. An indicator of cognitive impairment. Stroke 25: 1788–1793
Yamauchi H, Pagani M, Fukuyama H, Ouchi Y, Nagahama Y, Matsuzaki S, Kimura J, Yonekura Y, Konishi J (1995) Progression of atrophy of the corpus callosum with deterioration of cerebral cortical oxigen metabolism after carotid artery occlusion: a follow up study with MRI and PET. J Neurol Neurosurg Psychiatry 59: 420–426
Yoshii F, Duara R (1989) Size of corpus callosum in normal subjects and patients with Alzheimer–s disease. Clin Neurol (Tokyo) 29: 1–7
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag/Wien
About this paper
Cite this paper
Pantel, J. et al. (1998). Corpus callosum in Alzheimer’s disease and vascular dementia — a quantitative magnetic resonance study. In: Gertz, HJ., Arendt, T. (eds) Alzheimer’s Disease — From Basic Research to Clinical Applications. Journal of Neural Transmission. Supplementa, vol 54. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7508-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7508-8_12
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83112-0
Online ISBN: 978-3-7091-7508-8
eBook Packages: Springer Book Archive